Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering

Yanping Chen1*, Xiongwei Zheng1*, Gang Chen1*, Chen He1, Weifeng Zhu1, Shangyuan Feng2, Gangqin Xi2, Rong Chen2, Fenghua Lan3, Haishan Zeng41Pathology Department of Fujian Provincial Tumor Hospital, Teaching Hospital of Fujian Medical University, 2Key Laboratory of OptoElectronic Science and Technol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen YP, Zheng XW, Chen G, He C, Zhu WF, Feng SY, Xi G, Chen R, Lan FH, Zeng HS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/fe31bdd78c2c424bb03b9bdcddcd7d17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe31bdd78c2c424bb03b9bdcddcd7d17
record_format dspace
spelling oai:doaj.org-article:fe31bdd78c2c424bb03b9bdcddcd7d172021-12-02T05:09:44ZImmunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering1176-91141178-2013https://doaj.org/article/fe31bdd78c2c424bb03b9bdcddcd7d172011-12-01T00:00:00Zhttp://www.dovepress.com/immunoassay-for-lmp1-in-nasopharyngeal-tissue-based-on-surface-enhance-a8970https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Yanping Chen1*, Xiongwei Zheng1*, Gang Chen1*, Chen He1, Weifeng Zhu1, Shangyuan Feng2, Gangqin Xi2, Rong Chen2, Fenghua Lan3, Haishan Zeng41Pathology Department of Fujian Provincial Tumor Hospital, Teaching Hospital of Fujian Medical University, 2Key Laboratory of OptoElectronic Science and Technology for Medicine, Ministry of Education, Fujian Normal University, 3Research Center for Molecular Diagnosis of Genetic Diseases, Fuzhou General Hospital, Clinical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 4Imaging Unit, Integrative Oncology Department, British Columbia Cancer Agency Research Centre, Vancouver, Canada*These authors contributed equally to this workBackground: Previous studies have shown that Epstein–Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is closely associated with the occurrence and development of nasopharyngeal carcinoma, and can be used as a tumor marker in screening for the disease. Here we report a new methodology based on highly specific and sensitive surface-enhanced Raman scattering (SERS) technology to detect LMP1 in nasopharyngeal tissue sections directly with no need of tedious procedures as with conventional immunohistochemistry methods.Methods: LMP1-functionalized 4-mercaptobenzoic acid (4-MBA)-labeled Au/Ag core-shell bimetallic nanoparticles were prepared first and then applied for analyzing LMP1 in formalin-fixed paraffin-embedded nasopharyngeal tissue sections obtained from 34 cancer patients and 20 healthy controls. SERS spectra were acquired from a 25 × 25 spot square area on each tissue section and used to generate SERS images.Results: Data from SERS spectra and images show that this new SERS-based immunoassay detected LMP1 in formalin-fixed paraffin-embedded nasopharyngeal tissue sections with high sensitivity and specificity. The results from the new LMP1-SERS probe method are superior to those of conventional immunohistochemistry staining for LMP1, and in excellent agreement with those of in situ hybridization for EBV-encoded small RNA (EBER).Conclusion: This new SERS technique has the potential to be developed into a new clinical tool for detection and differential diagnosis of nasopharyngeal carcinoma as well as for predicting metastasis and immune-targeted treatment of nasopharyngeal carcinoma.Keywords: surface-enhanced Raman scattering, immunoassay, LMP1, nasopharyngeal carcinoma, in situ hybridization, immunohistochemistryChen YPZheng XWChen GHe CZhu WFFeng SYXi G, Chen RLan FHZeng HSDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 73-82 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Chen YP
Zheng XW
Chen G
He C
Zhu WF
Feng SY
Xi G, Chen R
Lan FH
Zeng HS
Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering
description Yanping Chen1*, Xiongwei Zheng1*, Gang Chen1*, Chen He1, Weifeng Zhu1, Shangyuan Feng2, Gangqin Xi2, Rong Chen2, Fenghua Lan3, Haishan Zeng41Pathology Department of Fujian Provincial Tumor Hospital, Teaching Hospital of Fujian Medical University, 2Key Laboratory of OptoElectronic Science and Technology for Medicine, Ministry of Education, Fujian Normal University, 3Research Center for Molecular Diagnosis of Genetic Diseases, Fuzhou General Hospital, Clinical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 4Imaging Unit, Integrative Oncology Department, British Columbia Cancer Agency Research Centre, Vancouver, Canada*These authors contributed equally to this workBackground: Previous studies have shown that Epstein–Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is closely associated with the occurrence and development of nasopharyngeal carcinoma, and can be used as a tumor marker in screening for the disease. Here we report a new methodology based on highly specific and sensitive surface-enhanced Raman scattering (SERS) technology to detect LMP1 in nasopharyngeal tissue sections directly with no need of tedious procedures as with conventional immunohistochemistry methods.Methods: LMP1-functionalized 4-mercaptobenzoic acid (4-MBA)-labeled Au/Ag core-shell bimetallic nanoparticles were prepared first and then applied for analyzing LMP1 in formalin-fixed paraffin-embedded nasopharyngeal tissue sections obtained from 34 cancer patients and 20 healthy controls. SERS spectra were acquired from a 25 × 25 spot square area on each tissue section and used to generate SERS images.Results: Data from SERS spectra and images show that this new SERS-based immunoassay detected LMP1 in formalin-fixed paraffin-embedded nasopharyngeal tissue sections with high sensitivity and specificity. The results from the new LMP1-SERS probe method are superior to those of conventional immunohistochemistry staining for LMP1, and in excellent agreement with those of in situ hybridization for EBV-encoded small RNA (EBER).Conclusion: This new SERS technique has the potential to be developed into a new clinical tool for detection and differential diagnosis of nasopharyngeal carcinoma as well as for predicting metastasis and immune-targeted treatment of nasopharyngeal carcinoma.Keywords: surface-enhanced Raman scattering, immunoassay, LMP1, nasopharyngeal carcinoma, in situ hybridization, immunohistochemistry
format article
author Chen YP
Zheng XW
Chen G
He C
Zhu WF
Feng SY
Xi G, Chen R
Lan FH
Zeng HS
author_facet Chen YP
Zheng XW
Chen G
He C
Zhu WF
Feng SY
Xi G, Chen R
Lan FH
Zeng HS
author_sort Chen YP
title Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering
title_short Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering
title_full Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering
title_fullStr Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering
title_full_unstemmed Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering
title_sort immunoassay for lmp1 in nasopharyngeal tissue based on surface-enhanced raman scattering
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/fe31bdd78c2c424bb03b9bdcddcd7d17
work_keys_str_mv AT chenyp immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT zhengxw immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT cheng immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT hec immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT zhuwf immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT fengsy immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT xigampnbspchenr immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT lanfh immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
AT zenghs immunoassayforlmp1innasopharyngealtissuebasedonsurfaceenhancedramanscattering
_version_ 1718400570753024000